JP7314494B2 - アミノ酸誘導体のプロドラッグを含有する医薬 - Google Patents

アミノ酸誘導体のプロドラッグを含有する医薬 Download PDF

Info

Publication number
JP7314494B2
JP7314494B2 JP2018195550A JP2018195550A JP7314494B2 JP 7314494 B2 JP7314494 B2 JP 7314494B2 JP 2018195550 A JP2018195550 A JP 2018195550A JP 2018195550 A JP2018195550 A JP 2018195550A JP 7314494 B2 JP7314494 B2 JP 7314494B2
Authority
JP
Japan
Prior art keywords
carbonyl
oxy
hexane
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018195550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019073507A (ja
JP2019073507A5 (https=
Inventor
憲一 大嶽
隆 端早田
洋平 松田
誠治 増田
裕子 山内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2019073507A publication Critical patent/JP2019073507A/ja
Publication of JP2019073507A5 publication Critical patent/JP2019073507A5/ja
Application granted granted Critical
Publication of JP7314494B2 publication Critical patent/JP7314494B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018195550A 2017-10-17 2018-10-17 アミノ酸誘導体のプロドラッグを含有する医薬 Active JP7314494B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017200722 2017-10-17
JP2017200722 2017-10-17

Publications (3)

Publication Number Publication Date
JP2019073507A JP2019073507A (ja) 2019-05-16
JP2019073507A5 JP2019073507A5 (https=) 2021-11-25
JP7314494B2 true JP7314494B2 (ja) 2023-07-26

Family

ID=66543765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018195550A Active JP7314494B2 (ja) 2017-10-17 2018-10-17 アミノ酸誘導体のプロドラッグを含有する医薬

Country Status (1)

Country Link
JP (1) JP7314494B2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024004505A (ja) * 2020-11-26 2024-01-17 大正製薬株式会社 アミノ酸誘導体の製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061698A1 (en) 2001-12-27 2003-07-31 Taisho Pharmaceutical Co.,Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
JP2004339199A (ja) 2003-04-23 2004-12-02 Taisho Pharmaceut Co Ltd グループｉｉメタボトロピックグルタミン酸受容体拮抗薬
WO2013180271A1 (ja) 2012-06-01 2013-12-05 大正製薬株式会社 含フッ素アミノ酸のプロドラッグ
JP2015127324A (ja) 2013-11-29 2015-07-09 大正製薬株式会社 含フッ素アミノ酸のプロドラッグを含有する医薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3445743B1 (en) * 2016-04-18 2021-08-04 Taisho Pharmaceutical Co., Ltd. Prodrug of amino acid derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061698A1 (en) 2001-12-27 2003-07-31 Taisho Pharmaceutical Co.,Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
JP2004339199A (ja) 2003-04-23 2004-12-02 Taisho Pharmaceut Co Ltd グループｉｉメタボトロピックグルタミン酸受容体拮抗薬
WO2013180271A1 (ja) 2012-06-01 2013-12-05 大正製薬株式会社 含フッ素アミノ酸のプロドラッグ
JP2015127324A (ja) 2013-11-29 2015-07-09 大正製薬株式会社 含フッ素アミノ酸のプロドラッグを含有する医薬

Also Published As

Publication number Publication date
JP2019073507A (ja) 2019-05-16

Similar Documents

Publication Publication Date Title
JP7787812B2 (ja) 置換大環状化合物および関連する治療方法
TWI761961B (zh) 稠合吡啶酮類化合物及其製備方法和應用
JP7045321B2 (ja) アミノ酸誘導体のプロドラッグ
JP6061857B2 (ja) モルヒナン誘導体
RU2734475C2 (ru) Разделение энантиомеров 3-этилбицикло [3.2.0] гепт-3-ен-6-она
JP7314494B2 (ja) アミノ酸誘導体のプロドラッグを含有する医薬
HK1260638B (zh) 氨基酸衍生物的前药
HK1260638A1 (en) Prodrug of amino acid derivative
US20110021625A1 (en) Neuronal cell death inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211015

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220905

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230324

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230529

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230613

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230626

R150 Certificate of patent or registration of utility model

Ref document number: 7314494

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150